Risto-cel Gene Therapy Shows High Fetal Hemoglobin and Elimination of Severe VOCs in Sickle Cell Disease: NEJM
USA: In an interim analysis of the phase I/II BEACON study, treatment with ristoglogene autogetemcel (risto-cel) demonstrated encouraging outcomes in patients with sickle cell disease.Participants achieved mean fetal hemoglobin levels…